Trial Profile
Phase II study of SNJ-2022; An exploration study in patients with primary open angle glaucoma or ocular hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Oct 2015
Price :
$35
*
At a glance
- Drugs Brimonidine (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- Sponsors Senju Pharmaceutical
- 02 Oct 2015 New trial record